Advanced search
Add to list

BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia

Sofie Peirs (UGent) , Filip Matthijssens (UGent) , Tim Pieters (UGent) , Niels Vandamme (UGent) , Geert Berx (UGent) , Bruce Poppe (UGent) and Pieter Van Vlierberghe (UGent)
(2016) CANCER RESEARCH. 76(suppl. 2).
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Peirs, Sofie, et al. “BRD4 Inhibition Improves the Efficacy of ABT-199 in T-Cell Acute Lymphoblastic Leukemia.” CANCER RESEARCH, vol. 76, no. suppl. 2, 2016.
APA
Peirs, S., Matthijssens, F., Pieters, T., Vandamme, N., Berx, G., Poppe, B., & Van Vlierberghe, P. (2016). BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia. CANCER RESEARCH, 76(suppl. 2).
Chicago author-date
Peirs, Sofie, Filip Matthijssens, Tim Pieters, Niels Vandamme, Geert Berx, Bruce Poppe, and Pieter Van Vlierberghe. 2016. “BRD4 Inhibition Improves the Efficacy of ABT-199 in T-Cell Acute Lymphoblastic Leukemia.” In CANCER RESEARCH. Vol. 76.
Chicago author-date (all authors)
Peirs, Sofie, Filip Matthijssens, Tim Pieters, Niels Vandamme, Geert Berx, Bruce Poppe, and Pieter Van Vlierberghe. 2016. “BRD4 Inhibition Improves the Efficacy of ABT-199 in T-Cell Acute Lymphoblastic Leukemia.” In CANCER RESEARCH. Vol. 76.
Vancouver
1.
Peirs S, Matthijssens F, Pieters T, Vandamme N, Berx G, Poppe B, et al. BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia. In: CANCER RESEARCH. 2016.
IEEE
[1]
S. Peirs et al., “BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia,” in CANCER RESEARCH, Atlanta, GA, USA, 2016, vol. 76, no. suppl. 2.
@inproceedings{6942309,
  articleno    = {{abstract B39}},
  author       = {{Peirs, Sofie and Matthijssens, Filip and Pieters, Tim and Vandamme, Niels and Berx, Geert and Poppe, Bruce and Van Vlierberghe, Pieter}},
  booktitle    = {{CANCER RESEARCH}},
  issn         = {{0008-5472}},
  language     = {{eng}},
  location     = {{Atlanta, GA, USA}},
  number       = {{suppl. 2}},
  title        = {{BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia}},
  volume       = {{76}},
  year         = {{2016}},
}

Web of Science
Times cited: